Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients

* Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort Study

Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage

* Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe